Financial Year |
March 31 2023 |
Monetary Funds |
3,467,329,925.41 |
Held-for-trading Financial Assets |
199,140,768.17 |
Notes Receivable |
5,549,705.67 |
Accounts Receivable |
4,502,475,249.93 |
Advances to Suppliers |
372,991,713.46 |
Other Receivables |
112,514,764.29 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
1,646,970,938.77 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
225,920,174.51 |
Total Current Assets |
10,699,881,046.98 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
9,121,187.39 |
Investment Properties |
376,123,045.01 |
Fixed Assetes |
5,803,820,838.98 |
Under-construction Projects |
595,931,442.71 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
728,944,559.65 |
R&D expenses |
-- |
Goodwill |
598,407,088.30 |
Long-Term Deferred and Prepaid Expenses |
224,593,429.29 |
Deferred Income Tax Assets |
97,672,407.20 |
Other Non-Current Assets |
290,840,333.75 |
Sub-Total of Non-Current Assets |
9,001,323,391.41 |
Total Assets |
19,701,204,438.39 |
Short-Term Loans |
3,543,148,169.95 |
Trading Financial liabilities |
-- |
Notes Payable |
673,550,149.88 |
Accounts Payable |
1,892,709,612.60 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
180,711,320.56 |
Taxes Payable |
64,278,601.55 |
Interest Payable |
-- |
Dividend Payable |
13,720,000.00 |
Other payables |
321,956,550.41 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
513,757,943.81 |
Other Current Liabilities |
5,803,541.03 |
Sub-Total of Current Liabilities |
7,296,316,975.99 |
Long-term Loans |
1,025,600,720.94 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
6,331,879.14 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
195,918,441.53 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,536,026,572.08 |
Total Liabilities |
8,832,343,548.07 |
Paid-In Capital(Or Share Stock) |
930,513,553.00 |
Capital Surplus |
1,903,654,606.38 |
Surplus Reserve |
424,762,560.12 |
LESS:Treasury Stock |
304,073,581.61 |
Undistributed Profits |
7,459,554,693.53 |
Minority Stockholder's Interest |
478,462,713.53 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,390,398,176.79 |
Owner's Equity(Stockholder's Equity) |
10,868,860,890.32 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
19,701,204,438.39 |